Rapid Differentiation of Joint Infections
Urgent Need for Accurate Postoperative Infection Testing
Accurate and rapid differentiation between postoperative inflammation and infection is critical, yet difficult with current diagnostic methods.
The global joint replacement market is projected to reach $38 billion by 2030. With the rising number of joint replacement surgeries, the demand for effective infection diagnostics is increasing, presenting a substantial market opportunity for SynoTact®.
Our Solution
A Game Changer
Precision in Postoperative Infection Detection
SynoTact® helps surgeons quickly differentiate between post-operative inflammation or bacterial infections, whether immediately or during follow-ups.
SynoTact® is designed for acute and chronic PJI detection, providing fast, reliable results from synovial fluid analysis to prevent unnecessary antibiotic use, reducing antibiotic resistance and avoiding prolonged hospital stays.
How SynoTact® works
No Sample Prep
Reader Agnostic
Actionable Results
Benefits to healthcare providers
Avoids Overuse of Antibiotics
Clinical Decision Support
Cost Savings
Prevents Severe Complications
Breakthrough Technology – The VIPER® platform detects active infections with accuracy and speed
SynoTact® is currently for research use only and is not for use in diagnostic procedures; the performance characteristics of this product have yet to be established.